JPS62263158A - Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof - Google Patents

Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof

Info

Publication number
JPS62263158A
JPS62263158A JP10470286A JP10470286A JPS62263158A JP S62263158 A JPS62263158 A JP S62263158A JP 10470286 A JP10470286 A JP 10470286A JP 10470286 A JP10470286 A JP 10470286A JP S62263158 A JPS62263158 A JP S62263158A
Authority
JP
Japan
Prior art keywords
water
methanol
separated
belonging
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10470286A
Other languages
Japanese (ja)
Inventor
Hideji Itokawa
糸川 秀治
Koichi Takeya
竹谷 孝一
Shunji Tsuruoka
鶴岡 俊志
Noboru Mori
森 登
Toru Sonobe
徹 薗部
Seiji Kosemura
誠治 小瀬村
Naoko Okamura
直子 岡村
Toshiko Ogawa
敏子 小川
Mikiko Oogoshi
大越 美希子
Kenji Yamakawa
健二 山川
Toshinori Hamanaka
濱中 敏議
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOUBISHI YAKUHIN KOGYO KK
Tobishi Pharmaceutical Co Ltd
Original Assignee
TOUBISHI YAKUHIN KOGYO KK
Tobishi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOUBISHI YAKUHIN KOGYO KK, Tobishi Pharmaceutical Co Ltd filed Critical TOUBISHI YAKUHIN KOGYO KK
Priority to JP10470286A priority Critical patent/JPS62263158A/en
Publication of JPS62263158A publication Critical patent/JPS62263158A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

NEW MATERIAL:The tetracyclic alkaloid FK 1000 of formula. USE:A carcinostatic agent. PREPARATION:Small chips of the root of a plant belonging to Cocculus trilobus harvested in autumn are extracted with methanol, etc., and a water-transferable fraction of the extract is treated with a spherical resin of a porous polymer such as Amberlite XAD-2. A fraction separated by using water as mobile phase is purified by silica gel column chromatography to obtain the objective substance.

Description

【発明の詳細な説明】 で表される制癌効果を有する新規な四環性アルカロイド
PKIO00及びその製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel tetracyclic alkaloid PKIO00 having an anticancer effect represented by: and a method for producing the same.

本発明になる化合物FK l 000を含有する防己科
木防己属の植物は日本ではツヅラフジ科アオツヅラフジ
属とよばれ、この科に属する植物としてオオツヅラフジ
、コウモリカズラ、アオッヅラフジ、ホウザンツヅラフ
ジ及びハスノハカズラなどがアジア、主に東南アジアか
ら東アジアに広く分布している。
In Japan, the plant of the genus Chrysanthemum, which contains the compound FK l 000 of the present invention, is called the genus Chrysanthemum, family Chrysanthemum, and plants belonging to this family, such as Chrysanthemum albicans, Chrysanthemum japonica, Chrysanthemum japonica, Chrysanthemum japonica, and Chrysanthemum japonica, are found in Asia. , widely distributed mainly from Southeast Asia to East Asia.

発明者らは広く植物のスクリーニングを進めた結果、ア
オツヅラフジ属のアオツヅラフジ、ホウザンツヅラフジ
の抽出エキスに制癌効果のあることを確かめ、この抽出
エキスを更に分画精製して強い制癌効果を有する化合物
の単離に成功してこの発明を完成したものである。従来
、この科の植物から単離されているアルカロイド類は、
その殆どが三級アミノ基を含むものであるのに対し、本
発明で得られた化合物PK100Oは二級アミノ基、エ
ノールエーテルを有する特異な溝造をもつ水溶性アルカ
ロイドであることが確認された。
As a result of extensive screening of plants, the inventors confirmed that the extracts of the genus Alocasia spp. and Alocasia spp. This invention was completed by successfully isolating the . The alkaloids conventionally isolated from plants of this family are
While most of them contain a tertiary amino group, the compound PK100O obtained in the present invention was confirmed to be a water-soluble alkaloid with a unique groove structure and a secondary amino group and an enol ether.

本発明になるFKlooOの抽出にあたってアオツヅラ
フジ属植物の葉茎を用いることら出来るが、含量からみ
て根部の細片を用いるのが有利であった。又、植物収穫
の時期によっても含有化合物の量は増減するが、発明者
らの知見によれば通常冬場のものは少なく秋場のものは
多く含有していた。この細片からの目的物の単離は例え
ばメタノールによる抽出エキスの水移行性画分について
アンバーライトXAD−2の如き多孔性ポリマーの球状
樹脂を用い水を移動相とした画分を採取し、更にシリカ
ゲルカラムクロマトを用い、精製して目的物が得られた
In the extraction of FKlooO according to the present invention, the leaves and stems of plants belonging to the genus Pygmyus can be used, but from the viewpoint of the content, it was advantageous to use pieces of the roots. Additionally, the amount of compounds contained increases or decreases depending on the time of plant harvest, but according to the findings of the inventors, those in winter usually contain less, and those in autumn usually contain more. Isolation of the target product from these pieces can be carried out by collecting the water-transferable fraction of the extract extracted with methanol using a porous polymer spherical resin such as Amberlite XAD-2 and using water as the mobile phase. Further purification was performed using silica gel column chromatography to obtain the desired product.

更に別の方法としては前記のメタノール抽出物に直接シ
リカゲルを用いた分離操作を施すことによってもよいが
、活性炭素、イオン交換樹脂を用いることによって、よ
り効率的に目的物を単離することができた。目的物の抽
出は該化合物が水に対する溶解性をも有するのでメタノ
ール単独のほか水を混和してもよく、その混和率は通常
のこのような化合物の植物からの抽出の際と同様に広い
範囲に調整できる。シリカゲルを用いる時はクロロホル
ム−メタノール系又はアセトン−メタノール−酢酸が溶
出液として使用でき、活性炭素の場合は塩基性溶液とし
た上、水−メタノール−酢酸又はメタノール−酢酸溶媒
で溶出する。塩基性溶液としてはアンモニア水溶液など
が用いられる。
Another method is to directly perform a separation operation using silica gel on the methanol extract, but the target product can be isolated more efficiently by using activated carbon or ion exchange resin. did it. For extraction of the target compound, since the compound has water solubility, water may be mixed in addition to methanol alone, and the mixing ratio can be varied over a wide range as in the case of ordinary extraction of such compounds from plants. It can be adjusted to When using silica gel, a chloroform-methanol system or acetone-methanol-acetic acid can be used as an eluent; in the case of activated carbon, a basic solution is used, and then elution is performed with a water-methanol-acetic acid or methanol-acetic acid solvent. As the basic solution, an ammonia aqueous solution or the like is used.

酢酸については強酸、鉱酸を使用することは目的物を破
壊するおそれがあるため不適当であるが同様な有機酸類
が使用できる。
Regarding acetic acid, it is inappropriate to use strong acids or mineral acids because they may destroy the target product, but similar organic acids can be used.

イオン交換樹脂としてはダウエックス50W−X2(ザ
・ダウ・ケミカル社製)の他ダイアイオンSKシリーズ
(三菱化成製)、アンバーライトrRシリーズ(オルガ
ノ社製)の如き陽イオン交換樹脂を用い、アンモニア水
溶液の如き塩基性溶液によって溶出させることができる
。この方法は更に活性炭素による精製を加えることによ
って、より効率よく目的物を得ることができ、この方法
によると特に精製水を使用する必要はなく、水道水など
を使用することら可能であった。又、本発明の目的物に
はアミノ基、水酸基が存在するところから、常法の如く
精製工程においてこれらの基にトリクロロエチルカルバ
メートなどの保護基を導入し、単離ののち離脱させるよ
うな操作ら単離工程中に於ける本発明目的物の損失を防
止するため有効な手段であった。
As the ion exchange resin, cation exchange resins such as DOWEX 50W-X2 (manufactured by The Dow Chemical Company), Diaion SK series (manufactured by Mitsubishi Kasei), and Amberlite rR series (manufactured by Organo) are used. It can be eluted with a basic solution such as an aqueous solution. This method can obtain the target product more efficiently by adding purification using activated carbon. According to this method, there is no need to use particularly purified water, and it is possible to use tap water etc. . In addition, since the object of the present invention has amino groups and hydroxyl groups, a protective group such as trichloroethyl carbamate is introduced into these groups in the purification process as in the conventional method, and removed after isolation. This was an effective means for preventing loss of the target product of the present invention during the isolation process.

抗腫瘍性試験 この試験ではP388マウス白血病細胞、ザルコーマ1
80A細胞を用いてin vivoに於ける抗腫瘍効果
を調べた。
Antitumor test In this test, P388 murine leukemia cells, Sarcoma 1
The antitumor effect in vivo was investigated using 80A cells.

試験方法 P388マウス白血病細胞 CDF、マウス1群各6匹の腹腔内にP388細胞lX
l0’個10.1mlを移植し、移植24時間後から1
日1回計5回FK1000の所定量を腹腔内に投与し、
FKlooO−を投与しないマウス群との間における延
命率の差を観測した。
Test method P388 mouse leukemia cells CDF, P388 cells 1X intraperitoneally of 1 group of 6 mice each
10.1ml of 10' cells were transplanted, and 10.1ml was transplanted 24 hours after transplantation.
Administer a prescribed amount of FK1000 intraperitoneally once a day for a total of 5 times,
The difference in survival rate between the mouse group and the mouse group to which FKlooO- was not administered was observed.

結果を表に示す。The results are shown in the table.

to     12.5±0.48   154.62
5    13.5±0.34   167.050 
   14.3±O0・49   177.3100 
   16.2±1.92   200.0対照   
8.08±0.15    to。
to 12.5±0.48 154.62
5 13.5±0.34 167.050
14.3±O0・49 177.3100
16.2±1.92 200.0 control
8.08±0.15 to.

ザルコーマ!80 アルピノマウス(ICR系)5週令雄1群6匹の腹腔内
に移植後7日目の腹水型のザルコーマ180を移植し、
移植後24時間から5日までの間に1日1回FK100
Oの所定量を腹腔内に投与し、PKlooOを投与しな
いマウス群との間における腫瘍成長率の差を観測した。
Sarcoma! 80 Ascites-type Sarcoma 180 was transplanted into the abdominal cavity of 5-week-old male Alpino mice (ICR strain), 6 mice per group, and 7 days after transplantation,
FK100 once daily from 24 hours to 5 days after transplantation
A predetermined amount of O was administered intraperitoneally, and the difference in tumor growth rate between a group of mice and a group of mice to which PKlooO was not administered was observed.

結果を表に示す。The results are shown in the table.

10    +0.7    0.32    76.
0  −20   −0.3    0.29    
83.2  −40    +1.6    0,37
    56.0   +以下本発明を実施例により説
明する。
10 +0.7 0.32 76.
0 -20 -0.3 0.29
83.2 -40 +1.6 0,37
56.0 +The present invention will be explained below with reference to Examples.

実施例1 アオツヅラフジの乾燥根6Kgをメタノール45Lで3
回抽出した溶液より669gの抽出エキスを得、このエ
キスを水1゜3Lに懸濁し、n−へキサン2して3回洗
浄ののち、更に酢酸エチル2して3回分液漏斗にて分配
し、水層を濃縮して553gの残渣を得た。この残渣を
イオン交換樹脂のアンバーライトXAD−2を充填した
あラムにかけ、水で溶出する両分を集め濃縮し、クロロ
ホルム−ジエチルアミン(3:2)を溶出溶媒とするシ
リカゲルカラムクロマトグラフィーによって分画し、シ
リカゲル薄層板でクロロホルム−ジエチルアミン(7:
3)を用いて展開した時、Rr値が0.32付近にスポ
ットが観察される画分を集め、再度濃縮して淡褐色無品
性粉末の目的物52gを得た。
Example 1 6 kg of dried roots of Aotsudurafuji were mixed with 45 L of methanol.
669 g of extracted extract was obtained from the solution extracted twice, and this extract was suspended in 1.3 L of water, washed three times with two portions of n-hexane, and then distributed three times with two portions of ethyl acetate using a separating funnel. , the aqueous layer was concentrated to obtain 553 g of residue. This residue was applied to an column packed with ion exchange resin Amberlite and chloroform-diethylamine (7:
3), the fractions in which spots were observed around Rr value of 0.32 were collected and concentrated again to obtain 52 g of the target product as a pale brown, indestructible powder.

比旋光度〔α〕6°ニー77.0°(c=0.1.Me
OH)I n : ν!!!Scm −’ 3400 
(br)U■:λuni!”nm (ε)  215(
16000)、234(8000)、283(2700
) MSIII/Z(%)  : 333(M”l 2)、
318(19)、258(+00)、244(16)、
200(3)115(5)、83(7) CD(c=9.67 X 10′S、MeOI−1)(
θ) ”(nm): +62100 (238)(po
sitive maximum)’ II −N M 
R(CD y OD )δ: 6.75(IH,d、J
 =8.3l−1z)[i、53(目I、d、J=8.
3Hz)、  4.35(II−I、d、J=6.1H
z)、4.28(IH,d、J=3.5Hz)、3.8
4(IH,ddd、J=13.3.3.7,3.5Hz
)、3.82(311,!3)、 3.68(31(、
s)、 3.1 5(I  H,dd、j =17.7
,6.111z)、2.90(IH,dd、J=13.
3゜3 、711z>、2.89(I H,d、J =
 17.7 )fz)、2,73(I  H,dd、J
=13.1.4.7H2)、  2.63(IH。
Specific optical rotation [α] 6° knee 77.0° (c=0.1.Me
OH) I n : ν! ! ! Scm-' 3400
(br)U■:λuni! ”nm (ε) 215(
16000), 234 (8000), 283 (2700
) MSIII/Z (%): 333 (M”l 2),
318 (19), 258 (+00), 244 (16),
200 (3) 115 (5), 83 (7) CD (c = 9.67 X 10'S, MeOI-1) (
θ) ”(nm): +62100 (238)(po
sitive maximum)' II -N M
R (CD y OD ) δ: 6.75 (IH, d, J
=8.3l-1z) [i, 53 (th I, d, J=8.
3Hz), 4.35 (II-I, d, J=6.1H
z), 4.28 (IH, d, J=3.5Hz), 3.8
4 (IH, ddd, J=13.3.3.7, 3.5Hz
), 3.82(311,!3), 3.68(31(,
s), 3.1 5 (I H, dd, j = 17.7
, 6.111z), 2.90 (IH, dd, J=13.
3゜3, 711z>, 2.89 (I H, d, J =
17.7) fz), 2,73 (I H, dd, J
=13.1.4.7H2), 2.63(IH.

ddd、J=13.1,12.5,3.4Hz)、2.
17(IH。
ddd, J=13.1, 12.5, 3.4Hz), 2.
17 (IH.

t、J=13.31−!z)、2.01(IH,dd、
J=12.7゜3.4Hz)、  1.88(IH,d
dd、J=12.7,12.5゜4 、7 Hz) 13C−NMrt(CD30D、δ、ppm) :  
I 47.67(s)、147゜B l (s)−14
5−72(s)、I 30−/l 0(s)、1299
5(s)、121.47(s)、119.51(d)、
110゜96(d)、68.57(d)、66.47(
d)、57.26(Q)56.95(q)、47.15
(d)、41.00(L)、39゜57(8)、37.
16(t)、36.78(t)、36.09(t)実施
例2 ホウザンツヅラフジ全草800gを10%メタノール水
2L。
t, J=13.31-! z), 2.01 (IH, dd,
J=12.7°3.4Hz), 1.88(IH, d
dd, J=12.7, 12.5°4, 7 Hz) 13C-NMrt (CD30D, δ, ppm):
I 47.67(s), 147°B l(s)-14
5-72(s), I 30-/l 0(s), 1299
5(s), 121.47(s), 119.51(d),
110°96(d), 68.57(d), 66.47(
d), 57.26 (Q) 56.95 (q), 47.15
(d), 41.00 (L), 39°57 (8), 37.
16(t), 36.78(t), 36.09(t) Example 2 800g of the whole plant of Houzanthuzurahuji was added to 2L of 10% methanol water.

水2 UX 5で抽出した溶液12Lに28%アンモニ
ア水を120m1加えてアルカリ性とし、この液に活性
炭素(和光純薬製)を100g加え30分程攪拌した。
120 ml of 28% ammonia water was added to 12 L of the solution extracted with 2 UX 5 water to make it alkaline, and 100 g of activated carbon (manufactured by Wako Pure Chemical Industries, Ltd.) was added to this liquid and stirred for about 30 minutes.

活性炭素を加えた抽出液をろ過し、ろ液が中性になるま
で水で洗浄ののち、メタノール−酢酸(100:1)に
て溶出させ約40℃で濃縮した。濃縮液を強酸性陽イオ
ン交換樹脂であるダウエックス50W−X2カラムに注
ぎ、精製水で非吸着域である酸性、中性成分を洗い流し
たのち、更に0.3規定、0.8規定、L2規定のアン
モニア水で洗浄し、1.5規定で溶出される両分を集め
、この溶液的2Lに20gの活性炭素を加え攪拌ののち
、ろ過した。ろ液が中性になるまで水で洗浄ののち、メ
タノール−酢酸(100:1)溶液にて溶出し、約40
℃で濃縮して淡褐色無定形のFKlooo  2.8g
を得た。
The extract containing activated carbon was filtered, washed with water until the filtrate became neutral, eluted with methanol-acetic acid (100:1), and concentrated at about 40°C. The concentrated solution was poured into a DOWEX 50W-X2 column, which is a strongly acidic cation exchange resin, and the acidic and neutral components in the non-adsorption area were washed away with purified water. It was washed with normal ammonia water, and the two fractions eluted at 1.5 normal were collected. 20 g of activated carbon was added to 2 L of this solution, stirred, and then filtered. After washing with water until the filtrate becomes neutral, it is eluted with a methanol-acetic acid (100:1) solution, and the
2.8 g of FKlooo is concentrated at °C to give a light brown amorphous form.
I got it.

I R: シ!:cm −’ 3400 (br)、1
670.1600、Uv:λ工!!”nm (g)  
260(3000)、287(3580)’H−NMR
(DtO−DSS)δ: 6.89(IH,d、J=8
.3Hz)、6.65(I H,d、J=8.3Hz)
、4.41(IH。
IR: Shi! :cm-' 3400 (br), 1
670.1600, Uv:λ Engineering! ! ”nm (g)
260 (3000), 287 (3580)'H-NMR
(DtO-DSS) δ: 6.89 (IH, d, J=8
.. 3Hz), 6.65 (IH, d, J=8.3Hz)
, 4.41 (IH.

d、J=6.1H2)、4.38(IH,d、J=3.
9H2)、3.99(IH,ddd、J=13.2,3
.9,3.7Hz)、3゜82 (3H,s)、3.6
8(3H,s)、3.19(IH,dd。
d, J=6.1H2), 4.38(IH, d, J=3.
9H2), 3.99 (IH, ddd, J=13.2,3
.. 9,3.7Hz), 3°82 (3H,s), 3.6
8 (3H, s), 3.19 (IH, dd.

J = 18.3,6.1 Hz)、2.92(IH,
d、J=18゜3Hz)、2.93−2.43(3H,
complex)、2.06(IH,dd、J=13.
4,13.4H2)、1.95〜1.82 (2H、c
omplex) ”C−NMR(DtO−DSS、δ、1)I)Il1)
 :  149.4(s)、147 、3 (s)、1
47 、1 (s)、132.5(s)、132.1(
s)、127.1(s)、121.0(d)、113.
3(d)、69.6(d)、67.5(d)、60.2
(Q)、59 、1 (Q)、47.8(d)、41.
8(t)、40.9(S)、39.0(t)、37.7
(t)、37.7(t) 実施例3 乾燥したアオツヅラフジの根茎0.8Kgをメタノール
3Lに室温にて浸漬し、得られた抽出液を実施例2と同
様に処理して2.0gのFK 1000を得た。
J = 18.3, 6.1 Hz), 2.92 (IH,
d, J=18°3Hz), 2.93-2.43(3H,
complex), 2.06 (IH, dd, J=13.
4,13.4H2), 1.95-1.82 (2H, c
complex) ”C-NMR (DtO-DSS, δ, 1) I) Il1)
: 149.4 (s), 147, 3 (s), 1
47, 1 (s), 132.5 (s), 132.1 (
s), 127.1(s), 121.0(d), 113.
3(d), 69.6(d), 67.5(d), 60.2
(Q), 59, 1 (Q), 47.8(d), 41.
8(t), 40.9(S), 39.0(t), 37.7
(t), 37.7 (t) Example 3 0.8Kg of dried rhizomes of P. elegans were immersed in 3L of methanol at room temperature, and the resulting extract was treated in the same manner as in Example 2 to obtain 2.0g of Obtained FK 1000.

実施例4 実施例3と同様にホウザンッヅラフジ0 、8 Kgを
処理し酢酸塩として2.4gのPKlooOを得た。
Example 4 In the same manner as in Example 3, 0 and 8 kg of PKlooO were treated to obtain 2.4 g of PKlooO as an acetate salt.

実施例5 実施例3に於けるメタノールの代わりに10%メタノー
ル水(2L)、続いて水(2LX5)を用いて抽出した
エキスより1゜9gのFK l 000を得た。
Example 5 1.9 g of FK 1 000 was obtained from the extract extracted using 10% methanol water (2 L) and then water (2 L x 5) instead of methanol in Example 3.

Claims (1)

【特許請求の範囲】 1)式 ▲数式、化学式、表等があります▼ で表されるFK1000化合物 2)防己科木防己属植物より抽出して得られるエキスを
分離精製することを特徴とする式 ▲数式、化学式、表等があります▼ で表されるFK1000化合物の製造方法
[Claims] 1) FK1000 compound represented by the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ 2) A formula characterized by separating and purifying an extract obtained by extracting from a plant of the genus Trifoliaceae ▲There are mathematical formulas, chemical formulas, tables, etc.▼ Manufacturing method of FK1000 compound represented by
JP10470286A 1986-05-09 1986-05-09 Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof Pending JPS62263158A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10470286A JPS62263158A (en) 1986-05-09 1986-05-09 Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10470286A JPS62263158A (en) 1986-05-09 1986-05-09 Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof

Publications (1)

Publication Number Publication Date
JPS62263158A true JPS62263158A (en) 1987-11-16

Family

ID=14387812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10470286A Pending JPS62263158A (en) 1986-05-09 1986-05-09 Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof

Country Status (1)

Country Link
JP (1) JPS62263158A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100480973B1 (en) * 2001-03-24 2005-05-17 (주)내츄럴엔도텍 Antagonistic Compositions Against Dioxin-like Compounds Comprising Extract of Cocculus trilobus
EP1589004A1 (en) * 2004-04-22 2005-10-26 Universite Pierre Et Marie Curie Paris Vi Alkaloid compounds and their use as anti-malarial drugs

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100480973B1 (en) * 2001-03-24 2005-05-17 (주)내츄럴엔도텍 Antagonistic Compositions Against Dioxin-like Compounds Comprising Extract of Cocculus trilobus
EP1589004A1 (en) * 2004-04-22 2005-10-26 Universite Pierre Et Marie Curie Paris Vi Alkaloid compounds and their use as anti-malarial drugs
WO2005103008A1 (en) * 2004-04-22 2005-11-03 Universite Pierre Et Marie Curie (Paris Vi) Alkaloid compounds and their use as anti-malarial drugs
WO2005103009A1 (en) * 2004-04-22 2005-11-03 Universite Pierre Et Marie Curie (Paris Vi) Alkaloid compounds and their use as anti-malarial drugs
JP2007533704A (en) * 2004-04-22 2007-11-22 ユニベルシテ ピエール エ マリー キュリー(パリ シズエム) Alkaloid compounds and their use as antimalarial agents
US7943633B2 (en) 2004-04-22 2011-05-17 Universite Pierre Et Marie Curie (Paris Vi) Alkaloid compounds and their use as anti-malarial drugs

Similar Documents

Publication Publication Date Title
US3896111A (en) Ansa macrolides
Pettit et al. Antineoplastic agents, 99. Amaryllis belladonna
DE69530706T2 (en) HUPERZINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE
JPS61197585A (en) Novel bliostatin 4-8
EP0402925A2 (en) A method of isolating ginkgolides from the leaves of the ginkgo tree and purifying them
Abou-Shoer et al. Antitumour and cytotoxic xanthones of Psorospermum febrifugum
JPS6222990B2 (en)
JPS62142181A (en) Novel tannin
JPS617285A (en) Extraction of purified saponin
JPS62263158A (en) Novel tetracyclic alkaloid fk separated from cocculus trilobus belonging to menispermaceae family and production thereof
JP5462996B2 (en) A hepatoprotective agent obtained from the bonsai, a pharmaceutical or food containing the hepatoprotectant, and a novel Megastigman compound obtained from the bonsai.
US4137231A (en) Process for the isolation of 2-hydroxymethyl-3,4,5-trihydroxypiperidine from plant material
JPS6011912B2 (en) tannin
Ali et al. Clivonidine, a new alkaloid from Clivia miniata
JPS6248677A (en) Novel tannin
CN108948038A (en) A kind of new red sandalwood alkane type flavone compound and application thereof
Oshio et al. Two new iridoid glucosides of Plantago asiatica
WO2007066926A1 (en) A mass production method of brazilein from caesalpinia sappan l
FI98889C (en) A method for preparing an antineoplastic drug derived from a plant extract
CA1123443A (en) Antileukemic trichotecene epoxides
JPS62289565A (en) Novel tetracyclic alkaloid fk and production thereof
Boyd et al. Quinoline alkaloids. Part X.(+)-Platydesminium salt and other alkaloids from Skimmia japonica Thunb. The synthesis of edulinine
Li et al. Two new diterpenoid alkaloids, beiwusines A and B, from Aconitum kusnezoffii
Oguakwa et al. Research on African Medicinal Plants. XI1 8-Hydroxycolumbin, A New Furanoid Diterpene from Chasmanthera dependens
IE921545A1 (en) Antineoplastic chemotherapeutic of plant origin, having high¹selectivity and greatly reduced toxicity, and process for¹the preparation thereof